[Possibilities for the external regulation of lysosomal structure and functions. Pharmacological effects on the permeability of lysosomal membranes in the ischemic myocardium].
Sysoliatina
N A
NA
Sapozhkov
A V
AV
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D006728:Hormones / Q000627:therapeutic use; D007425:Intracellular Membranes / Q000187:drug effects* / Q000201:enzymology; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D009203:Myocardial Infarction / Q000188:drug therapy / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D011453:Prostaglandins / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D006728:Hormones; D011453:Prostaglandins; D000242:Cyclic AMP; D006152:Cyclic GMP
Vozmozhnosti vneshneĭ reguliatsii struktury i funktsiĭ lizosom. Farmakologicheskie vliianiia na pronitsaemost' lizosomal'nykh membran ishemizirovannogo miokarda.